See What HealthDay Can Do For You
Contact Us

Three Scientists Share Nobel Prize for Hepatitis C Research

Nobel Committee described their work as 'a landmark achievement in our battle against viral infections'

human liver

MONDAY, Oct. 5, 2020 (HealthDay News) -- Two U.S. researchers and a British scientist have been awarded the 2020 Nobel Prize in physiology or medicine for major contributions to the fight against blood-borne hepatitis.

Hepatitis C causes 400,000 deaths worldwide each year, The Washington Post reported.

The three recipients are: Harvey Alter, a clinical scientist at a U.S. National Institutes of Health blood bank; Charles Rice, of Washington University in St. Louis; and British-born virologist Michael Houghton.

The researchers' work was described by the Nobel Committee as "a landmark achievement in our battle against viral infections," The Post reported.

The Washington Post Article

Physician's Briefing

HealthDay

HealthDay is the world’s largest syndicator of health news and content, and providers of custom health/medical content.

Consumer Health News

A health news feed, reviewing the latest and most topical health stories.

Professional News

A news feed for Health Care Professionals (HCPs), reviewing latest medical research and approvals.